| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director And CEO, Alkermes Plc
2 companies
Pops Richard F is a Director And CEO, Alkermes Plc at ALKS, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 59 sales. Those positions are worth an estimated $46.2M at current prices.
Our model assigns Pops Richard F a middling insider score of 57/100, based on 12 past trades. Over a 12-month horizon, 41.7% of those trades were profitable, with an average 12-month return of -2.8%.
Pops Richard F's largest disclosed position is in ALKS as Director And CEO, Alkermes Plc, worth about $46.2M. The recent filings there lean toward selling, a net 2,232,257 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | NBIX Neurocrine Biosciences, Inc. | Director | Sale+OE | 15,000 | $157.65 | $2,364,760.50 | -30.3% | - | - | |
| May 17, 2024 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 2,100 | $141.84 | $297,860.43 | -6.2% | +3.9% | -14.9% | |
| Mar 13, 2024 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 23,200 | $140.33 | $3,255,621.20 | -44.0% | -6.1% | -23.1% | |
| Mar 11, 2024 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 1,800 | $140.04 | $252,078.03 | -5.7% | -2.8% | -22.6% | |
| Feb 20, 2024 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 15,000 | $132.47 | $1,987,047.00 | -33.7% | +6.8% | -13.9% | |
| Jan 3, 2023 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 15,000 | $119.20 | $1,788,045.00 | -33.7% | -16.0% | +10.5% | |
| May 9, 2022 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 15,000 | $76.30 | $1,144,462.50 | -33.7% | +38.0% | +28.3% | |
| May 6, 2022 | ALKS Alkermes Plc. | Director And CEO, Alkermes Plc | Sale+OE | 347,257 | $27.98 | $9,717,783.63 | -26.4% | -6.3% | +6.6% | |
| May 18, 2021 | ALKS Alkermes Plc. | Director And CEO, Alkermes Plc | Sale+OE | 150,000 | $21.90 | $3,285,405.00 | -15.9% | +28.4% | +31.9% | |
| May 11, 2021 | ALKS Alkermes Plc. | Director And CEO, Alkermes Plc | Sale+OE | 150,000 | $22.09 | $3,313,339.27 | -15.9% | +27.9% | +18.2% |